Frontlight ResearchEarly access
CompletedNo phase
Population-based Investigation of Aneurysm Incidence
Key facts
- Who runs it
- Beijing Tiantan Hospital
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 4,711 people enrolled
- Started
- 1 Oct 2023
- Ended
- 28 Feb 2025
- Type of study
- Interventional
- Treatments tested
- blood test
- Record updated
- 16 May 2025
Who can take part
- Age
- 35 years to 75 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Age 35-75
- Individuals with normal cognitive and communication abilities
- No serious complications, such as uncontrolled hypertension, diabetes or other chronic diseases that may affect the test results
- Basic blood test is normal or close to normal range
Who cannot take part
- There are metal implants, including dentures, pacemakers, etc
- Using or recently used drugs that may affect blood biomarkers ( such as anticoagulant drugs, immunosuppressive agents, etc. )
- Severe heart disease, renal insufficiency, liver dysfunction and other major diseases
- In the past 6 months, there were strokes, or other types of intracranial tumors, infections and other diseases that may affect the screening results
- There are serious mental illness or cognitive dysfunction, such as claustrophobia, unable to cooperate with the completion of the test
- Pregnancy
- It is currently participating in other clinical trials or has participated in other clinical trials in the past 3 months
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Most intracranial aneurysms are found accidentally in neurovascular imaging. And these inspection methods are limited by the problems of instrument fixation, radiation, time-consuming, contrast agent toxicity and so on. At present, blood test is an ideal alternative method for early diagnosis. Compared with imaging examination, it is economical, general screening and convenient. Blood test is simple to operate, easy to be accepted by patients, and less invasive. Early screening of aneurysms can be performed.
The group in the trial
- blood test groupTreatment being tested
Treatment: blood test
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 16 May 2025